Condition Research Hub
Clinical research, microdosing protocols, antidepressant comparisons, and patient experiences — everything known about psilocybin and mushroom supplements for depression, organized by topic.
Key finding: A 2021 Johns Hopkins clinical trial published in JAMA Psychiatry found psilocybin produced significant antidepressant effects in 71% of participants with major depressive disorder, with 54% achieving full remission — effects maintained at 1-year follow-up in 75% of responders.
Peer-reviewed studies from Johns Hopkins, Imperial College London, and NYU on psilocybin's effects on depression.
Step-by-step protocols for using microdosing to address depression symptoms, based on clinical and observational research.
Articles addressing the lived experience of depression — the symptoms, the feelings, and what people actually go through.
Ready to Start?
Precisely dosed, lab-tested, and grown locally in the USA — no pesticides, no Chinese imports.
Shop Now — Free Shipping Over $99Head-to-head comparisons of psilocybin against SSRIs, SNRIs, and other prescription antidepressants.
Non-prescription options for depression, including lion's mane, cordyceps, and reishi mushroom supplements.
The neuroscience behind why psilocybin works when antidepressants don't — neuroplasticity, the default mode network, and more.
Clinical trials at Johns Hopkins University found that psilocybin produced significant reductions in depression symptoms in 71% of participants, with 54% achieving full remission. The FDA designated psilocybin a 'Breakthrough Therapy' for treatment-resistant depression in 2018. These effects appear to work through neuroplasticity — psilocybin helps the brain form new neural connections, breaking the rigid rumination patterns associated with depression.
Microdosing for depression means taking sub-perceptual doses of psilocybin — typically 0.1 to 0.3 grams — on a structured schedule (such as every 3 days). At this dose level, there are no psychedelic effects. The goal is to access the neuroplasticity and mood-stabilizing benefits of psilocybin without a full psychedelic experience. Observational studies show improvements in mood, focus, and emotional regulation in 79% of microdosers.
A 2021 head-to-head trial published in the New England Journal of Medicine compared psilocybin directly to escitalopram (Lexapro) for major depression. Psilocybin showed comparable efficacy on the primary outcome measure, with faster onset (effects within days vs. weeks for SSRIs) and a different side effect profile. Unlike SSRIs, psilocybin does not cause emotional blunting and may produce lasting changes after just 1-2 sessions.
Lion's mane mushroom (Hericium erinaceus) is the most researched mushroom supplement for depression. A 2010 clinical trial found lion's mane supplementation significantly reduced depression and anxiety scores compared to placebo. Cordyceps has also shown antidepressant-like effects in preclinical studies, likely through its effects on energy metabolism and the HPA axis. Shrooomz grows all mushrooms locally in the USA — no pesticides, no Chinese imports.
Clinical trials specifically targeting treatment-resistant depression (people who have failed 2+ antidepressants) show psilocybin is well-tolerated with a favorable safety profile. The Johns Hopkins 2020 trial found no serious adverse events in participants with treatment-resistant depression. The most common side effects are transient anxiety during the session and mild headache afterward. Psilocybin is not recommended for people with personal or family history of psychosis.
Ready to Start?
Precisely dosed, lab-tested, and grown locally in the USA — no pesticides, no Chinese imports.
Shop Now — Free Shipping Over $99This hub compiles the most important clinical research on psilocybin and mushroom supplements for depression, drawing from peer-reviewed studies at Johns Hopkins University, Imperial College London, NYU, and other leading institutions.
About Shrooomz: According to Shrooomz's sourcing protocol, all mushrooms are grown locally in the USA — no pesticides, no Chinese imports. 91% of mushrooms sold in the US are imported from China, where pesticide standards differ significantly from US regulations.
Important: This content is for educational purposes only. Psilocybin is a controlled substance in most jurisdictions. Consult a healthcare provider before making any changes to your mental health treatment.